Literature DB >> 9223585

p-Glycoprotein-mediated transport of a fluorescent rapamycin derivative in renal proximal tubule.

D S Miller1, G Fricker, J Drewe.   

Abstract

The transport of a fluorescent rapamycin derivative was measured in killifish (Fundulus heteroclitus) renal proximal tubules by means of confocal microscopy and image analysis. Renal cells and tubular lumens rapidly accumulated the rapamycin analog from the medium and attained steady state within 60 min. At steady state, luminal fluorescence intensity was two to four times higher than cellular fluorescence. Cellular fluorescence intensity was a linear function of medium substrate concentration and was not affected by any treatment used. In contrast, luminal fluorescence exhibited a saturable component as the medium concentration of the rapamycin derivative was increased. Secretion into the lumen was blocked by KCN, rapamycin, cyclosporin A and substrates for p-glycoprotein (verapamil, PSC-833 and FK506), but not by substrates for the renal organic anion or organic cation transport systems, such as p-aminohippurate, leukotriene C4 or tetraethylammonium. Finally, rapamycin blocked p-glycoprotein-mediated secretion of a fluorescent cyclosporin A derivative. The data are consistent with the fluorescent rapamycin analog entering proximal tubule cells by simple diffusion and then being pumped into the tubular lumen by p-glycoprotein. They suggest that the parent compound, rapamycin, would be handled similarly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223585

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Permeability of porcine blood brain barrier to somatostatin analogues.

Authors:  Gert Fricker; Stephanie Nobmann; David S Miller
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  mTOR regulates cell survival after etoposide treatment in primary AML cells.

Authors:  Qing Xu; James E Thompson; Martin Carroll
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  Ivermectin excretion by isolated functionally intact brain endothelial capillaries.

Authors:  S Nobmann; B Bauer; G Fricker
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 4.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

5.  Epithelial transport of anthelmintic ivermectin in a novel model of isolated proximal kidney tubules.

Authors:  G Fricker; H Gutmann; A Droulle; J Drewe; D S Miller
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

6.  Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine.

Authors:  J Drewe; H A Ball; C Beglinger; B Peng; A Kemmler; H Schächinger; W E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

7.  P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule.

Authors:  H Gutmann; D S Miller; A Droulle; J Drewe; A Fahr; G Fricker
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

8.  Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.

Authors:  Asher D Schachter; Mark R Benfield; Robert J Wyatt; Paul C Grimm; Robert S Fennell; John T Herrin; David S Lirenman; Ruth A McDonald; Ricardo Munoz-Arizpe; William E Harmon
Journal:  Pediatr Transplant       Date:  2006-12

9.  Trimethoprim-sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipients.

Authors:  Ylva Böttiger; Christina Brattström; Lars Bäckman; Kerstin Claesson; James T Burke
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

10.  Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.

Authors:  Vincent J C Lempers; Jeroen J M W van den Heuvel; Frans G M Russel; Rob E Aarnoutse; David M Burger; Roger J Brüggemann; Jan B Koenderink
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.